McIntosh G H, McMurchie E J, James M, Lawson C A, Bulman F H, Charnock J S
Arteriosclerosis. 1987 Mar-Apr;7(2):159-65. doi: 10.1161/01.atv.7.2.159.
Common marmosets were fed a standard marmoset diet (REF) or diets supplemented with 12% (wt/wt) sunflower seed oil (SSO) or sheep fat (SF) for a period of 90 weeks. The values for coagulation indices, clotting time, and Russel viper venom time were consistent with decreased thrombotic tendency of platelets from animals on the SSO diet relative to the low fat, REF diet animals, while an increased tendency to thrombosis was observed with SF-fed marmosets. The SSO- and SF-supplemented marmosets showed a significantly reduced thromboxane (TXB2) generation from platelets aggregating to collagen (ASC) relative to the REF group, while at 50 micrograms/ml ASC this difference was maintained only by the SSO group. The SF diet-fed marmosets showed a reduced prostacyclin (measured as 6-keto-PGF1 alpha) generation from incubated aorta relative to the REF or SSO-fed groups, which were not different from each other. A reduced proportion of platelet phospholipid arachidonic acid (20:4, n-6) and increased alpha-tocopherol concentration was consistent with the decreased aggregability and thromboxane generation of platelets from SSO-fed marmosets relative to the REF and SF groups. The SF diet-fed marmosets, on the other hand, showed minimal change in arachidonic acid, alpha-tocopherol or platelet reactivity from the REF group. These differing responses to dietary fats are discussed in relation to the potential for the development of thrombosis and atherosclerosis.
普通狨猴被喂食标准狨猴饮食(REF)或添加了12%(重量/重量)向日葵籽油(SSO)或羊脂(SF)的饮食,为期90周。凝血指标、凝血时间和罗素蝰蛇毒时间的值表明,相对于低脂REF饮食的动物,食用SSO饮食的动物血小板的血栓形成倾向降低,而食用SF的狨猴则观察到血栓形成倾向增加。相对于REF组,添加SSO和SF的狨猴血小板聚集到胶原蛋白(ASC)时血栓素(TXB2)生成显著减少,而在50微克/毫升ASC时,这种差异仅在SSO组中保持。与REF或SSO喂养组相比,食用SF饮食的狨猴孵育主动脉中前列环素(以6-酮-PGF1α衡量)生成减少,而REF组和SSO组之间没有差异。相对于REF组和SF组,食用SSO的狨猴血小板磷脂花生四烯酸(20:4,n-6)比例降低和α-生育酚浓度增加,与血小板聚集性和血栓素生成减少一致。另一方面,食用SF饮食的狨猴与REF组相比,花生四烯酸、α-生育酚或血小板反应性变化最小。本文讨论了这些对膳食脂肪的不同反应与血栓形成和动脉粥样硬化发展可能性的关系。